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(57) ABSTRACT 
Antigenic molecules and compositions described herein 
protect against infection by typhoidal and non-typhoidal 
Salmonella serovars. Methods of immunization comprise 
the use of the antigenic molecules. 
3 Claims, 19 Drawing Sheets 
Specification includes a Sequence Listing. 

































































